Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors
Human Gene Therapy · 2026
DOI: 10.1177/10430342251386006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2026. Verfasst von Kyoko Masumi-Koizumi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Transfection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Recombinant adeno-associated virus (rAAV) vectors are among the most effective for gene therapy. A significant advancement in rAAV vector production is developing the triple-plasmid transfection method, which remains the most widely used technique. In this study, we used Expi293F TM (Expi293F) and Viral Production Cells 2.0 (VPC2.0 cells) to evaluate various transfection reagents, comparing transgene protein expression levels and intracellular plasmid copy numbers to optimize rAAV production. Our findings indicated that the effectiveness of transfection reagents in promoting higher rAAV production was cell-dependent and that rAAV productivity correlated more with plasmid levels in the cell nucleus than with transgene protein expression levels. Confocal laser microscopy revealed that in cells transfected with the high-yield transfection reagent, a large amount of free plasmid DNA entered the nucleus, whereas the transfection reagents themselves did not. These results provide new insights into the intracellular mechanisms underlying efficient rAAV vector production. Furthermore, identifying transfection reagents that facilitate nuclear plasmid delivery will aid in the selection of optimal reagents for high-yield AAV production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Masumi-Koizumi, K., Ito-Kudo, E., Yuan, Y., Hashiba, N., Yusa, K., & Uchida, K. (2026). Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors. Human Gene Therapy. https://doi.org/10.1177/10430342251386006
Vancouver
Masumi-Koizumi K, Ito-Kudo E, Yuan Y, Hashiba N, Yusa K, Uchida K. Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors. Human Gene Therapy. 2026. doi:10.1177/10430342251386006
BibTeX
@article{MasumiKoizumi2026,
author = {Masumi-Koizumi, Kyoko and Ito-Kudo, Emi and Yuan, Yuzhe and Hashiba, Noriko and Yusa, Keisuke and Uchida, Kazuhisa},
title = {Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors},
journal = {Human Gene Therapy},
year = {2026},
doi = {10.1177/10430342251386006}
}
EUVIMED